Exclusive: Pfizer negotiating 2-3 percent Allergan break-up fee - sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Enanta Pharma (ENTA) Receives $30M Milestone from AbbVie
November 20, 2015 9:06 AM ESTEnanta Pharma (NASDAQ: ENTA) disclosed the following on Friday morning:
Enanta Pharmaceuticals, Inc. has earned a $30 million milestone payment from AbbVie following the recent price reimbursement approval in Japan of AbbVies VIEKIRAX treatment for HCV infection, which had been approved for regulatory... More
New Treasury Guidelines on Inversion May Not Apply to Allergan (AGN)/Pfizer (PFE) - Evercore ISI's Raffat
November 20, 2015 8:33 AM ESTThere's lots of analyst chatter this morning on the pending Allergan (NYSE: AGN), Pfizer (NYSE: PFE) deal amid the... More
